Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Resistance is futile: making drugs from bugs

30.03.2006
Antibiotic resistance is a major problem worldwide and there is an urgent need for new antibiotics to be developed. Potential new drugs are usually made in the lab which is complicated and time-consuming. An international team of scientists are using bacteria found naturally in the soil to produce new antibiotics in the fight against drug-resistant “Super-bugs” such as MRSA.

Led by Professor Tony Maxwell of the John Innes Centre (Norwich, UK) [1] and Professor Lutz Heide of the Pharmazeutisches Institut, Tübingen (Germany) [2], the team has developed ways of engineering harmless soil bacteria called Streptomyces to do the difficult chemistry for them. Streptomyces naturally make antibiotics to kill other bacteria in the soil. Unfortunately these don’t make very good drugs for use in humans because they are not very soluble in water and so cannot get into the bloodstream easily. The researchers have found a way to modify the bacteria to manufacture new varieties of these antibiotics that could be developed into more effective drugs. By studying variations of two natural antibiotics produced by Streptomyces, called novobiocin and clorobiocin, the scientists are determining which parts of the molecules are essential for their antibacterial activity. They hope that by varying other parts of the molecules they can design new antibiotics with better activity and fewer side effects.

Novobiocin and clorobiocin work by interfering with how DNA, the molecule that stores genetic information, is packed into the bacterial cell. The DNA in human cells is packed differently and so these cells are not affected by the antibiotics.

“This work is an excellent example of the European Union [3] at its best, combining the forces of seven labs from five different member states to carry out work that would not be possible by in lab working alone” said Tony Maxwell “We are very optimistic that we can make key discoveries about these antibiotics that will help them become vital weapons in our fight against MRSA and other bacterial infections”.

This exciting work is published this week in the journal Antimicrobial Agents and Chemotherapy [4] and will also be discussed at an event in Norwich as part of the BA Festival of Science in September 2006 [5].

Notes:

1.The John Innes Centre (JIC), Norwich, UK is an independent, world-leading research centre in plant and microbial sciences. The JIC has over 800 staff and students. JIC carries out high quality fundamental, strategic and applied research to understand how plants and microbes work at the molecular, cellular and genetic levels. The JIC also trains scientists and students, collaborates with many other research laboratories and communicates its science to end-users and the general public. www.jic.ac.uk. he JIC is grant-aided by the Biotechnology and Biological Sciences Research Council.

2.Pharmazeutisches Institut, Auf der Morgenstelle 8, D-72076 Tübingen, Germany. Tel.: +49 7071-29 72460

3.This work is published in the journal Antimicrobial Agents and Chemotherapy (Volume 50, issue 4) (Publishers: American Society for Microbiology).

4.This work was funded by a grant from the European Commission (Combigyrase LSHB-CT-2004-503466).

5.The BA (British Association for the Advancement of Science) Annual Festival of Science runs from 2nd-9th September 2006 in Norwich, and is the biggest public science event in the UK. It is expected to attract over 10,000 people from around the world with the theme of “People, Science and Society”.

Professor Tony Maxwell | alfa
Further information:
http://www.jic.ac.uk

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>